"En la capital de España, el Grupo HLA dispone del centro de mayor capacidad asistencial del grupo: el Hospital HLA Universitario Moncloa. Este centro con una clara orientación y vocación docente, tiene una superficie total de 33000 m2, distribuidos en 4 plantas. Cuenta con 220 habitaciones individuales con cama de acompañante, 7 suites premium, 12 suites con salón, 13 puestos de U.C.I., 14 quirófanos para alta cirugía (2 oftalmológicos), 1 paritorio, 62 áreas y unidades asistenciales de atención especializada, 43 consultas de especialidades, Unidad de Reanimación Post-Quirúrgica, nido, central de esterilización y un completo Hospital de Día. Centro implicado con la calidad y excelencia, con múltiples certificaciones nacionales e internacio"

During the past decade, Clínica Moncloa conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clínica Moncloa" #1 sponsor was "PETHEMA Foundation" with 3 trials, followed by "Terumo Europe N.V." with 2 trials sponsored, "CABYC" with 1 trials sponsored, "Cimera" with 1 trials sponsored and "Fondazione per la Ricerca Ospedale Maggiore" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica Moncloa" #1 collaborator was "European Leukemia Net" with 1 trials as a collaborator, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clínica Moncloa" are "Coronary Artery Disease" (2 trials), "Multiple Myeloma" (2 trials), "Acute Promyelocytic Leukemia" (1 trials), "Asthma" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Clínica Moncloa" in a lesser frequency.

Most popular intervention types in "Clínica Moncloa" are "Drug" (6 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-methyl-prednisolone" (1 trials), "ATRA" (1 trials), "Allogenic Transplantation" (1 trials), "Arsenic Trioxide" (1 trials) and "Autologous Transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clínica Moncloa" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Clínica Moncloa". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clínica Moncloa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clínica Moncloa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".